НовостиBenzingaCitizens Maintains Market Outperform on IRulya Therapeutics, Raises Price Target to $86 Citizens Maintains Market Outperform on IRulya Therapeutics, Raises Price Target to $86 Benzinga 2026.11.16 14:00 (GMT+0) Открыть на Benzinga Другие новости